Frontiers in Medicine 2026 - Full Video
From Stanford Medicine · · 58 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.
If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.
Description
Join us for Frontiers in Medicine 2026—an exploration of the multiplier phenomenon in medicine and research; the idea that when the right minds collaborate, progress accelerates exponentially.
Hear from Stanford researchers and clinicians who demonstrate that principle—a chemist and oncologist joining forces against pancreatic cancer, a cardiologist working with oncologists to solve a problem created by cancer cures, and an engineer and radiologist developing a profoundly better stroke intervention. Joining them are leaders Dean Lloyd Minor, MD, and President and CEO David Entwistle, sharing how Stanford’s deeply integrated approach to patient care, research, and education creates an ecosystem where multipliers like these thrive—and how your partnership amplifies every discovery they make.
You won’t want to miss this powerful reminder that together we can accomplish more than we can on our own.
Steven Corsello, MD Assistant Professor of Medicine–Oncology
Nathanael Gray, PhD Krishnan-Shah Family Professor Professor of Chemical and Systems Biology
On the Hunt for a Pancreatic Cancer Cure Pancreatic cancer remains one of medicine’s most difficult challenges, with limited therapeutic options and high mortality rates. A uniquely Stanford duo, a drug-developing chemist and a drug-repurposing oncologist, are working together to flip that reality. Get an inside-the-lab look at how this team identifies and validates new therapeutic targets and hear about their newest promising breakthrough—a first-in-class treatment for pancreatic cancer that tricks cancer cells into destroying the proteins they need to grow.
Han Zhu, MD Assistant Professor of Medicine–Cardiovascular Medicine
Protecting the Heart During Cancer Therapy Cancer immunotherapies have transformed patient survival, yet these same life-saving treatments can themselves cause life-threatening inflammation of the heart, a condition called myocarditis. Cardiologist Han Zhu is working with oncologists across every cancer specialty to solve this problem. Learn about how her lab discovered the first biological roadmap of immunotherapy-induced myocarditis and is developing one of the first targeted therapeutic strategies—a groundbreaking effort that could transform how clinicians worldwide safeguard patients’ hearts during cancer treatment.
Jeremy Heit, MD, PhD Professor of Radiology Chief of Neuroimaging and Neurointervention
Renee Zhao, PhD Assistant Professor of Mechanical Engineering
Revolutionizing Stroke Care with a Tiny Clot-Busting Robot In the crucial moments after a stroke, when a blood clot is blocking an artery to the brain, time becomes the enemy. Standard catheter-based clot removal only works about 50% of the time on the first attempt. But a tiny robot being developed at Stanford has nearly doubled that success rate. Hear about the fortuitous collaboration between mechanical engineer Renee Zhao and neurointerventional radiologist Jeremy Heit to perfect the milli-spinner, a device that effectively removes blood clots 90% of the time in lab and animal models.